Heiner Dreismann joins Noscendo’s Board of Directors
Noscendo, a leading diagnostic company for identification and assessment of bloodstream associated pathogens and other infections has appointed Heiner Dreismann, former President and CEO of Roche Molecular Systems, to its Board of Directors.
